• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Qual Life Res . Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up

tetano

Editor, Senior Moderator
Qual Life Res


. 2021 May 12.
doi: 10.1007/s11136-021-02865-7. Online ahead of print.
Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up


Lorenzo Gamberini[SUP] 1 [/SUP], Carlo Alberto Mazzoli[SUP] 1 [/SUP], Harri Sintonen[SUP] 2 [/SUP], Davide Colombo[SUP] 3 4 [/SUP], Gaetano Scaramuzzo[SUP] 5 [/SUP], Davide Allegri[SUP] 6 [/SUP], Tommaso Tonetti[SUP] 7 [/SUP], Gianluca Zani[SUP] 8 [/SUP], Chiara Capozzi[SUP] 9 [/SUP], Emanuela Giampalma[SUP] 10 [/SUP], Vanni Agnoletti[SUP] 11 [/SUP], Filippo Becherucci[SUP] 12 [/SUP], Elisabetta Bertellini[SUP] 13 14 [/SUP], Andrea Castelli[SUP] 9 [/SUP], Iacopo Cappellini[SUP] 12 [/SUP], Irene Cavalli[SUP] 7 [/SUP], Federico Crimaldi[SUP] 13 14 [/SUP], Federica Damiani[SUP] 15 [/SUP], Maurizio Fusari[SUP] 8 [/SUP], Giovanni Gordini[SUP] 1 [/SUP], Cristiana Laici[SUP] 16 [/SUP], Maria Concetta Lanza[SUP] 17 [/SUP], Mirco Leo[SUP] 18 [/SUP], Andrea Marudi[SUP] 13 14 [/SUP], Giuseppe Nardi[SUP] 19 [/SUP], Irene Ottaviani[SUP] 5 [/SUP], Raffaella Papa[SUP] 20 [/SUP], Antonella Potalivo[SUP] 19 [/SUP], Vito Marco Ranieri[SUP] 7 [/SUP], Emanuele Russo[SUP] 11 [/SUP], Stefania Taddei[SUP] 21 [/SUP], Carlo Alberto Volta[SUP] 5 [/SUP], Savino Spadaro[SUP] 22 [/SUP], ICU-RER COVID-19 Collaboration



Collaborators, Affiliations

Abstract

Purpose: The onset of the coronavirus disease 19 (COVID-19) pandemic in Italy induced a dramatic increase in the need for intensive care unit (ICU) beds for a large proportion of patients affected by COVID-19-related acute respiratory distress syndrome (ARDS). The aim of the present study was to describe the health-related quality of life (HRQoL) at 90 days after ICU discharge in a cohort of COVID-19 patients undergoing invasive mechanical ventilation and to compare it with an age and sex-matched sample from the general Italian and Finnish populations. Moreover, the possible associations between clinical, demographic, social factors, and HRQoL were investigated.
Methods: COVID-19 ARDS survivors from 16 participating ICUs were followed up until 90 days after ICU discharge and the HRQoL was evaluated with the 15D instrument. A parallel cohort of age and sex-matched Italian population from the same geographic areas was interviewed and a third group of matched Finnish population was extracted from the Finnish 2011 National Health survey. A linear regression analysis was performed to evaluate potential associations between the evaluated factors and HRQoL.
Results: 205 patients answered to the questionnaire. HRQoL of the COVID-19 ARDS patients was significantly lower than the matched populations in both physical and mental dimensions. Age, sex, number of comorbidities, ARDS class, duration of invasive mechanical ventilation, and occupational status were found to be significant determinants of the 90 days HRQoL. Clinical severity at ICU admission was poorly correlated to HRQoL.
Conclusion: COVID-19-related ARDS survivors at 90 days after ICU discharge present a significant reduction both on physical and psychological dimensions of HRQoL measured with the 15D instrument.
Trial registration: NCT04411459.

Keywords: 15D instrument; Acute respiratory distress syndrome; COVID-19; Coronavirus; Health-related quality of life.
 
Back
Top Bottom